Evidence map›Paper›PMID 31553665›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2019

Protease Activity in Vascular Disease.

Megan A Slack, Scott M Gordon

Open access · bronzeAbstract readReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  5. Article
  6. Activatable Photosensitizers: From Fundamental Principles to Advanced Designs.Angewandte Chemie (International ed. in English) · 2025
    Review
  7. Article
  8. Vascular Extracellular Matrix in Atherosclerosis.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Peptidome Profiling ofAntibiotics (Basel, Switzerland) · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Molecular mechanisms of coronary artery disease risk at thebioRxiv : the preprint server for biology · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Megan A SlackFrom the Saha Cardiovascular Research Center and Department of Physiology, University of Kentucky College of Medicine, Lexington.
Scott M GordonFrom the Saha Cardiovascular Research Center and Department of Physiology, University of Kentucky College of Medicine, Lexington.
University of Kentucky · US

Funding

Graduate Training in Integrative PhysiologyT32GM118292 · NIGMS · UNIVERSITY OF KENTUCKY · PI CAMPBELL, KENNETH S · 2017 to 2021
$999k
The Role of High Density Lipoprotein Associated Protease Inhibitor Activity in Protection Against Atherosclerosis.K22HL141299 · NHLBI · UNIVERSITY OF KENTUCKY · PI GORDON, SCOTT M · 2018 to 2020
$734k
NHLBI NIH HHS K22 HL141299NIGMS NIH HHS T32 GM118292
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AneurysmAnimalsAtherosclerosisBiomarkersHumansPeptide HydrolasesPrognosisSensitivity and SpecificityThrombosisVascular DiseasesBiomarkersPeptide Hydrolasesaneurysmatherosclerosiscytokinesextracellular matrixinflammation

Identifiers

PMID31553665
PMCPMC6764587
OpenAlexW2976353749

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.